BriaCell Therapeutics Corp. (BCT.TO)
5.91
-0.01
(-0.17%)
CAD |
TSX |
Sep 18, 16:00
BriaCell Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Kane Biotech, Inc. | -143.2% |
| Quest PharmaTech, Inc. | -- |
| Vaxil Bio Ltd. | -- |
| Waverley Pharma, Inc. | 29.06% |
| Goldcoast Resource Corp. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -169.2% |
| Return on Assets | -138.7% |
| Return on Invested Capital | -169.2% |
| Return on Net Operating Assets | -1.79K% |